Randomised, Double-blind, Placebo-controlled Trial of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China.
Phase of Trial: Phase III
Latest Information Update: 15 Jan 2013
At a glance
- Drugs Zanamivir (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Therapeutic Use
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Nov 2011 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.